This
page
is
part
of
the
FHIR
Specification
(v4.0.1:
R4
-
Mixed
Normative
and
STU
)
in
it's
permanent
home
(it
will
always
be
available
at
this
URL).
(v4.2.0:
R5
Preview
#1).
The
current
version
which
supercedes
this
version
is
5.0.0
.
For
a
full
list
of
available
versions,
see
the
Directory
of
published
versions
.
Page
versions:
R4
R3
R2
4.3.15.252
HL7
Version
2
Table
0252
This
is
a
table
defined
as
part
of
HL7
v2
.
Summary
Code
System
URL:
http://terminology.hl7.org/CodeSystem/v2-0252
Value
Set
URL:
http://terminology.hl7.org/ValueSet/v2-0252
Version:
2.9
Name:
v2.0252
Title:
v2
Causality
Observations
Definition:
FHIR
Value
set/code
system
definition
for
HL7
v2
table
0252
(
Causality
Observations)
OID:
??
CodeSystem
Resource
XML
/
JSON
ValueSet
Resource
XML
/
JSON
Note:
V2
code
systems
may
or
may
not
be
case
sensitive.
V2
Code
systems
will
have
the
CodeSystem.caseSensitive
correctly
populated
in
a
future
version
of
this
specification.
This
value
set
is
not
currently
used
4.3.15.252.1
Code
System
Content
This
code
system
http://terminology.hl7.org/CodeSystem/v2-0252
defines
the
following
codes:
Code
Display
Definition
Version
AW
en:
Abatement
of
event
after
product
withdrawn
nl:
Vermindering
gebeurtenis
na
terugtrekken
product
added
v2.3
BE
en:
Event
recurred
after
product
reintroduced
nl:
Gebeurtenis
trad
opnieuw
op
na
herintroductie
product
added
v2.3
DR
en:
Dose
response
observed
nl:
Dosis
reactie
geobserveerd
added
v2.3
EX
en:
Alternative
explanations
for
the
event
available
nl:
Alternatieve
verklaringen
voor
gebeurtenis
beschikbaar
added
v2.3
IN
en:
Event
occurred
after
product
introduced
nl:
Gebeurtenis
trad
op
na
introductie
product
added
v2.3
LI
en:
Literature
reports
association
of
product
with
event
nl:
Literatuur
vermeldt
koppeling
van
product
met
gebeurtenis
added
v2.3
OE
en:
Occurrence
of
event
was
confirmed
by
objective
evidence
nl:
Optreden
van
gebeurtenis
is
bevestigd
door
objectief
bewijs
added
v2.3
OT
en:
Other
nl:
Anders
added
v2.3
PL
en:
Effect
observed
when
patient
receives
placebo
nl:
Effect
geobserveerd
wanneer
patiënt
placebo
krijgt
added
v2.3
SE
en:
Similar
events
in
past
for
this
patient
nl:
Vergelijkbare
gebeurtenissen
in
verleden
voor
deze
patiënt
added
v2.3
TC
en:
Toxic
levels
of
product
documented
in
blood
or
body
fluids
nl:
Toxische
niveaus
van
product
gedocumenteerd
in
bloed
of
lichaamssappen
added
v2.3
This
code
system
http://terminology.hl7.org/CodeSystem/v2-0252
defines
the
following
codes:
Code
Display
Definition
Version
AW
Abatement
of
event
after
product
withdrawn
added
v2.3
BE
Event
recurred
after
product
reintroduced
added
v2.3
DR
Dose
response
observed
added
v2.3
EX
Alternative
explanations
for
the
event
available
added
v2.3
IN
Event
occurred
after
product
introduced
added
v2.3
LI
Literature
reports
association
of
product
with
event
added
v2.3
OE
Occurrence
of
event
was
confirmed
by
objective
evidence
added
v2.3
OT
Other
added
v2.3
PL
Effect
observed
when
patient
receives
placebo
added
v2.3
SE
Similar
events
in
past
for
this
patient
added
v2.3
TC
Toxic
levels
of
product
documented
in
blood
or
body
fluids
added
v2.3
Dit
code
systeem
http://terminology.hl7.org/CodeSystem/v2-0252
definieert
de
volgende
codes:
Code
Display
Definition
Versie
AW
Vermindering
gebeurtenis
na
terugtrekken
product
added
v2.3
BE
Gebeurtenis
trad
opnieuw
op
na
herintroductie
product
added
v2.3
DR
Dosis
reactie
geobserveerd
added
v2.3
EX
Alternatieve
verklaringen
voor
gebeurtenis
beschikbaar
added
v2.3
IN
Gebeurtenis
trad
op
na
introductie
product
added
v2.3
LI
Literatuur
vermeldt
koppeling
van
product
met
gebeurtenis
added
v2.3
OE
Optreden
van
gebeurtenis
is
bevestigd
door
objectief
bewijs
added
v2.3
OT
Anders
added
v2.3
PL
Effect
geobserveerd
wanneer
patiënt
placebo
krijgt
added
v2.3
SE
Vergelijkbare
gebeurtenissen
in
verleden
voor
deze
patiënt
added
v2.3
TC
Toxische
niveaus
van
product
gedocumenteerd
in
bloed
of
lichaamssappen
added
v2.3